Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has announced the closure of its trading window starting Wednesday, October 1, 2025, in line with SEBI's insider trading rules. The closure applies to all designated persons, their immediate relatives, and connected persons, meaning they cannot buy or sell the company's shares during this period. The reason for the closure is the upcoming announcement of the company's unaudited financial results for the quarter and half year ended September 30, 2025. The trading window will reopen 48 hours after these results are officially declared to the stock exchanges. The exact date of the board meeting to approve these results will be communicated later.
This is a routine regulatory compliance announcement and has no direct impact on shareholders or the stock price. It is standard practice before quarterly results to prevent insider trading, and the window will reopen shortly after results are announced.